<code id='A95A899D5C'></code><style id='A95A899D5C'></style>
    • <acronym id='A95A899D5C'></acronym>
      <center id='A95A899D5C'><center id='A95A899D5C'><tfoot id='A95A899D5C'></tfoot></center><abbr id='A95A899D5C'><dir id='A95A899D5C'><tfoot id='A95A899D5C'></tfoot><noframes id='A95A899D5C'>

    • <optgroup id='A95A899D5C'><strike id='A95A899D5C'><sup id='A95A899D5C'></sup></strike><code id='A95A899D5C'></code></optgroup>
        1. <b id='A95A899D5C'><label id='A95A899D5C'><select id='A95A899D5C'><dt id='A95A899D5C'><span id='A95A899D5C'></span></dt></select></label></b><u id='A95A899D5C'></u>
          <i id='A95A899D5C'><strike id='A95A899D5C'><tt id='A95A899D5C'><pre id='A95A899D5C'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:11
          Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT
          Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

          WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

          Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

          advertisement

          Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          In 'major milestone,' FDA approves first cell therapy for solid tumors
          In 'major milestone,' FDA approves first cell therapy for solid tumors

          MetastaticmelanomacellsJulioC.Valencia,/NCICenterforCancerResearchNearlyfourdecadesafteritsfirstconc

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          New study raises questions about niacin and heart health

          MattRourke/APNiacin,orvitaminB3,haslongbeenaU.S.publichealthdarlingtothepointthatitisadded,bylaw,toc